{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 1150"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Federal Food, Drug, and Cosmetic Act to\n\t\t  preserve the effectiveness of medically important antimicrobials used in the\n\t\t  treatment of human and animal diseases."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130314", "#text": "March 14, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": "\n\t\t\t introduced the following bill; which was referred to the\n\t\t\t ", "#text": "Ms. Slaughter", "@name-id": "S000480"}, "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and\n\t\t\t Commerce"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H43E6A9A134B844788FE7B4136905D95C", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Preservation of Antibiotics for\n\t\t\t Medical Treatment Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the\n\t\t\t ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H31F72AF810FF45438D365278EDD8A63B"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "The Congress finds the following:", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " concluded that feeding livestock low doses of antibiotics\n\t\t\t used in human disease treatment could promote the development of\n\t\t\t antibiotic-resistance in bacteria. However, the ", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t Drug Administration", "@entity-id": "7524"}, {"#tail": "\n\t\t\t did not act in response to these findings, despite laws requiring the agency to\n\t\t\t do so.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "In 1977, the "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n          ", "@id": "HECBCC072259B48F281ADEC19BA71C970", "@commented": "no"}, {"@indent": "up1", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " was ordered by a Federal court to address the use of antibiotics\n\t\t\t in livestock, as the result of a lawsuit filed against the agency citing the\n\t\t\t agency\u2019s failure to act in response to the 1977 findings.", "@entity-type": "federal-body", "#text": "Food and Drug\n\t\t\t Administration", "@entity-id": "7524"}, "#text": "In 2012, the "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "#text": "\n          ", "@id": "HD48CA5749A4B4D898093E9D9933E8086"}], "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H7471AAFF10B94B359C0989567BCF16E1", "#text": "\n        "}, {"#tail": "\n      ", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "In 1998, the National\n\t\t\t Academy of Sciences noted that antibiotic-resistant bacteria generate a minimum\n\t\t\t of $4,000,000,000 to $5,000,000,000 in costs to United States society and\n\t\t\t individuals yearly."}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n          ", "@id": "H20B636BFA3334EC5940E633B9D066F36", "@commented": "no"}, {"@indent": "up1", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "In 2009, Cook County Hospital and the\n\t\t\t Alliance for Prudent Use of Antibiotics estimated that the total health care\n\t\t\t cost of antibiotic resistant infections in the United States was between\n\t\t\t $16,600,000,000 and $26,000,000,000 annually."}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "#text": "\n          ", "@id": "HC0917E10669849DF8586AB9DADC0CFF2"}], "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "HF2EEF440566D4B02AAA567ABBBAA5F84", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " concluded that resistant strains\n\t\t\t of 3 microorganisms that cause food-borne illness or disease in humans\n\t\t\t (Salmonella, Campylobacter, and E. coli) are linked to the use of antibiotics\n\t\t\t in animals.", "@entity-type": "federal-body", "#text": "Government Accountability Office", "@entity-id": "0500"}, "#text": "An April 1999\n\t\t\t study by the "}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "@id": "H9F158C47A05542ACBAB484C323876AC3", "#text": "\n        "}, {"#tail": "\n      ", "subparagraph": [{"@display-inline": "yes-display-inline", "#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2019s Animal and Plant Health Inspection\n\t\t\t Service in 1999, 2001, and 2006 revealed that\u2014", "@entity-type": "federal-body", "#text": "Department of Agriculture", "@entity-id": "1200"}, "#text": "Large-scale, voluntary\n\t\t\t surveys by the "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "clause": [{"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "84 percent of grower-finisher swine\n\t\t\t farms, 83 percent of cattle feedlots, and 84 percent of sheep farms administer\n\t\t\t antimicrobials in the feed or water for health or growth promotion reasons;\n\t\t\t and"}, "enum": {"#tail": "\n            ", "#text": "(i)"}, "#text": "\n            ", "@id": "HA1C13C474754420A8E2CAD4012D2EC35"}, {"@indent": "up1", "#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "many of the antimicrobials\n\t\t\t identified are identical or closely related to drugs used in human medicine,\n\t\t\t including tetracyclines, macrolides, Bacitracin, penicillins, and sulfonamides;\n\t\t\t and"}, "enum": {"#tail": "\n            ", "#text": "(ii)"}, "#text": "\n            ", "@id": "HC6D72AD182794FF8A1DD1CC0C254F9C6"}], "#text": "\n          ", "@id": "HA795F2B98D83424CADB41DD6980512B7", "@commented": "no"}, {"@indent": "up1", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "these drugs are used in people to\n\t\t\t treat serious diseases such as pneumonia, scarlet fever, rheumatic fever,\n\t\t\t sexually transmitted infections, skin infections, and even pandemics like\n\t\t\t malaria and plague, as well as bioterrorism agents like smallpox and\n\t\t\t anthrax."}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "#text": "\n          ", "@id": "H56D1035DB5EC4804AC296761AFF62BBF"}], "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "H2D57DEFE85BE4B72AFC52B143881F488", "#text": "\n        "}, {"#tail": "\n      ", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "Any overuse or misuse of\n\t\t\t antibiotics contributes to the spread of antibiotic resistance, whether in\n\t\t\t human medicine or in agriculture."}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n          ", "@id": "HCBFE13D291CB408B904A0F6CE05CDF25", "@commented": "no"}, {"@indent": "up1", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Recognizing the public health threat\n\t\t\t caused by antibiotic resistance, Congress took several steps to curb antibiotic\n\t\t\t overuse in human medicine through amendments to the ", "{http://namespaces.cato.org/catoxml}entity": [{"#tail": ") made by ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n\t\t\t (", "@entity-type": "act", "#text": "Public Health Service Act", "@value": "Public Health Service Act"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "42 U.S.C. 201 et seq.", "@value": "usc/42/201/etseq"}, "@parsable-cite": "usc/42/201", "#text": "\n                ", "@legal-doc": "usc"}}, {"#tail": ", but has not yet\n\t\t\t addressed antibiotic overuse in agriculture.", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 102 of the Public Health Threats and\n\t\t\t Emergencies Act", "@value": "Public Health Threats and Emergencies Act/s:102"}, {"#tail": "; ", "@entity-type": "public-law", "#text": "\n                ", "external-xref": {"#tail": ", title I", "@parsable-cite": "pl/106/505", "#text": "Public Law 106\u2013505", "@legal-doc": "public-law"}, "@value": "public-law/106/505"}, {"#tail": ")", "@entity-type": "statute-at-large", "#text": "114 Stat. 2315", "@value": "statute-at-large/114/2315"}], "@entity-type": "law-citation", "#text": "\n              "}]}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "#text": "\n          ", "@id": "H059E1AA384174ABD9EEA1FFF09E5C399"}], "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "H081D1D683E8D4332A8CAF4016CB53F8A", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "In January 2001, a\n\t\t\t Federal interagency task force\u2014"}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "#text": "\n        ", "@id": "HA8EA3834C3184F57B85BAAA0387A3758", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "released an action\n\t\t\t plan to address the continuing decline in effectiveness of antibiotics against\n\t\t\t common bacterial infections, referred to as antibiotic resistance;"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H5F954BF2B94E4F4D95AC20CE980ED9F9", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "determined that\n\t\t\t antibiotic resistance is a growing menace to all people and poses a serious\n\t\t\t threat to public health; and"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "HDA61A7A17BD74E1CA4FF661846BA2914", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "cautioned that if\n\t\t\t current trends continue, treatments for common infections will become\n\t\t\t increasingly limited and expensive, and, in some cases, nonexistent."}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@id": "H3749189634B84799A1D289C9C7994F30", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " reported in March 2002 that\u2014", "@entity-type": "federal-body", "#text": "United States\n\t\t\t Geological Survey", "@entity-id": "1434"}, "#text": "The "}, "enum": {"#tail": "\n        ", "#text": "(7)"}, "#text": "\n        ", "@id": "H0920E6AE5B5045A49CAC36AA6BDA1621", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "antibiotics were\n\t\t\t present in 48 percent of the streams tested nationwide; and"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H22AB292129B74AC49B2DDDA7A3EA63D8", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "almost half of the\n\t\t\t tested streams were downstream from agricultural operations."}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "H2E818F3072234CC2996CA8B3DD02B18F", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": {"#tail": " published a report in June\n\t\t\t 2002 that\u2014", "#text": "Clinical Infectious Diseases"}, "#text": "The peer-reviewed\n\t\t\t journal "}, "enum": {"#tail": "\n        ", "#text": "(8)"}, "#text": "\n        ", "@id": "HCD522506C63A4508AB117F113AB636AF", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "was based on a\n\t\t\t 2-year review by experts in human and veterinary medicine, public health,\n\t\t\t microbiology, biostatistics, and risk analysis, of more than 500 scientific\n\t\t\t studies on the human health impacts of antimicrobial use in agriculture;\n\t\t\t and"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "HECB6062BA06F4F3484F424F3E26C6C55", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "recommended that\n\t\t\t antimicrobial agents should no longer be used in agriculture in the absence of\n\t\t\t disease, but should be limited to therapy for diseased individual animals and\n\t\t\t prophylaxis when disease is documented in a herd or flock."}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "H0F8E7002B90645799A89F4E1A1CD3481", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "In a March 2003\n\t\t\t report, the National Academy of Sciences stated that\u2014"}, "enum": {"#tail": "\n        ", "#text": "(9)"}, "#text": "\n        ", "@id": "HBDB9002730F848E3ADE768D88DB7C66E", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "a decrease in\n\t\t\t antimicrobial use in human medicine alone will have little effect on the\n\t\t\t current situation; and"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "HC4532FACBC0D4A65BCC9B9FE9EB244EF", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "substantial\n\t\t\t efforts must be made to decrease inappropriate overuse in animals and\n\t\t\t agriculture."}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "H1492929C313E4E75AE5A4A23756875D5", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Federal Food,\n\t\t\t Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et seq.", "@value": "usc/21/301/etseq"}, "@parsable-cite": "usc/21/301", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(10)"}, "#text": "\n        ", "@id": "H2C8EA9C1E442451EAC1BC9D96E5DEFA5", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "requires that all\n\t\t\t drugs be shown to be safe before the drugs are approved; and"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H027B21D67105491BADB6DF54AB815E70", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "places the burden\n\t\t\t on manufacturers to account for health consequences and prove safety."}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "HF47E6E0D47FF40C797EED165412D6719", "#text": "\n          "}]}, {"#tail": "\n      ", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " modified the drug approval process for antibiotics to\n\t\t\t recognize the development of resistant bacteria as an important aspect of\n\t\t\t safety, but most antibiotics currently used in animal production systems for\n\t\t\t nontherapeutic purposes were approved before the ", "@entity-type": "federal-body", "#text": "Food and\n\t\t\t Drug Administration", "@entity-id": "7524"}, {"#tail": "\n\t\t\t began considering resistance during the drug-approval process.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}], "#text": "In 2003, the "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n          ", "@id": "H691454AD26BA4B588139CD11248B39AD", "@commented": "no"}, {"@indent": "up1", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " has\n\t\t\t not established a schedule for reviewing those existing approvals.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "#text": "\n          ", "@id": "HDD68A150B5A042DFB9520013E86A618E"}], "enum": {"#tail": "\n        ", "#text": "(11)"}, "@id": "HAA02866992464DB7B29A748D74283A3A", "#text": "\n        "}, {"#tail": "\n      ", "subparagraph": [{"@display-inline": "yes-display-inline", "#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "federal-body", "#text": "Government Accountability Office", "@entity-id": "0500"}, "#text": "In an April 2004 report,\n\t\t\t the "}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "clause": [{"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "concluded that Federal agencies do\n\t\t\t not collect the critical data on antibiotic use in animals that they need to\n\t\t\t support research on human health risks; and"}, "enum": {"#tail": "\n            ", "#text": "(i)"}, "#text": "\n            ", "@id": "H28B82A8B14E74F519A2C90523CB0F439"}, {"@indent": "up1", "#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " and the ", "@entity-type": "federal-body", "#text": "Department of\n\t\t\t Agriculture", "@entity-id": "1200"}, {"#tail": " develop and\n\t\t\t implement a plan to collect data on antibiotic use in animals.", "@entity-type": "federal-body", "#text": "Department of Health and Human Services", "@entity-id": "7500"}], "#text": "recommended that the "}, "enum": {"#tail": "\n            ", "#text": "(ii)"}, "#text": "\n            ", "@id": "H7378768DFAFE4FB59B99BDB1CD370E10"}], "#text": "\n          ", "@id": "H977A87F7CF004673895C016E7827EF8B", "@commented": "no"}, {"@indent": "up1", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "federal-body", "#text": "Government Accountability Office", "@entity-id": "0500"}, "#text": "In a September 2011 update to that\n\t\t\t report, the "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "clause": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "concluded that Federal agencies had\n\t\t\t made limited progress in addressing antibiotic use in animals;"}, "enum": {"#tail": "\n            ", "#text": "(i)"}, "@id": "H8FA85011BF7F4134BC79B61BA705934A", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "recommended that Federal agencies\n\t\t\t fund research on alternatives to current antibiotic use practices; and"}, "enum": {"#tail": "\n            ", "#text": "(ii)"}, "@id": "HB1939AD1E29C4D6C876F52AAC04014F6", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2019s voluntary guidelines reducing antibiotic use in food animals.", "@entity-type": "federal-body", "#text": "FDA", "@entity-id": "7524"}, "#text": "recommended that Federal agencies\n\t\t\t track the effectiveness of policies that curb antibiotic resistance, including\n\t\t\t "}, "enum": {"#tail": "\n            ", "#text": "(iii)"}, "@id": "H1161EAF1413D4B128B262A5740A2AB6B", "#text": "\n            "}], "#text": "\n          ", "@id": "H178E444AEBFA4B9EB0F8BD52BB014493"}], "enum": {"#tail": "\n        ", "#text": "(12)"}, "@id": "HF8619BBE79504ECEAFC08C9E1A945EBB", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "In 2009, the\n\t\t\t Congressional Research Service concluded that without restrictions on the use\n\t\t\t of antimicrobial drugs in the production of livestock, export markets for\n\t\t\t livestock and poultry could be negatively impacted due to restrictions on the\n\t\t\t use of antibiotics in other nations."}, "enum": {"#tail": "\n        ", "#text": "(13)"}, "@id": "H38A40CDAEAD64DCE81331A3DEA35B0AE", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "quote": {"#tail": " published a study\n\t\t\t demonstrating that low-dosage use of antibiotics causes a dramatic increase in\n\t\t\t genetic mutation, raising new concerns about the agricultural practice of using\n\t\t\t low-dosage antibiotics in order to stimulate growth promotion and routinely\n\t\t\t prevent disease in unhealthy conditions.", "#text": "Molecular Cell"}, "#text": "In 2010, the\n\t\t\t peer-reviewed journal "}, "enum": {"#tail": "\n        ", "#text": "(14)"}, "@id": "H77D6E51A63554A1C9A31DD5BD3E0D92E", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "In 2010, the\n\t\t\t Danish Veterinary and Food Administration testified that the Danish ban of the\n\t\t\t nontherapeutic use of antibiotics in food animal production resulted in a\n\t\t\t marked reduction in antimicrobial resistance in multiple bacterial species,\n\t\t\t including Campylobacter and Enterococci."}, "enum": {"#tail": "\n        ", "#text": "(15)"}, "@id": "HC18F715C09944D3D80AD2A7AF15706CB", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " determined that\u2014", "@entity-type": "federal-body", "#text": "Food\n\t\t\t and Drug Administration", "@entity-id": "7524"}, "#text": "In 2011, the "}, "enum": {"#tail": "\n        ", "#text": "(16)"}, "#text": "\n        ", "@id": "HBE7306DEEE884DEFB4249C84D883B20F", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "13.5 million\n\t\t\t kilograms of antibacterial drugs were sold for use on food animals in the\n\t\t\t United States in 2010;"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "H0FB7812190EB4FF392F967F14DEBBC3F", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "3.3 million\n\t\t\t kilograms of antibacterial drugs were used for human health in 2010; and"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "HB33E3863082F4992907CD04AD7F16479", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "therefore, 80\n\t\t\t percent of antibacterial drugs disseminated in the United States in 2010 were\n\t\t\t sold for use on food animals, rather than being used for human health."}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@id": "HDB6EAB8CDDC445DE870AFB6D26BE1035", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "In 2011, a review\n\t\t\t of all scientific studies on antimicrobial use in farm animals, published in\n\t\t\t Clinical Microbiology Reviews, found that\u2014"}, "enum": {"#tail": "\n        ", "#text": "(17)"}, "#text": "\n        ", "@id": "HE5F975E915934BC1AE5AF6938A9D86F9", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "use of antibiotics\n\t\t\t in food animals leads to development of reservoirs of antibiotic\n\t\t\t resistance;"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "HA63082A1D4474959B8BD524DDF71C25F", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "a ban on\n\t\t\t antibiotic use in food animals would preserve their use for medicine;\n\t\t\t and"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "HEB3EFA5098F14CF4A9124220336C1BC6", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "a Danish ban on\n\t\t\t antibiotics in food animals resulted in little change in animal morbidity and\n\t\t\t mortality, and only a modest increase in production cost."}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@id": "H7B228642303E40D68E65796F7470B276", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " issued voluntary guidance to industry on\n\t\t\t reducing antibiotic use in livestock and poultry. As part of that guidance, it\n\t\t\t summarized over 35 years of peer-reviewed scientific literature regarding use\n\t\t\t of antimicrobial drugs in livestock. As a result, ", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, {"#tail": " stated strategies for\n\t\t\t controlling antibiotic resistance are needed, and are seeking voluntarily\n\t\t\t limits on antibiotic use.", "@entity-type": "federal-body", "#text": "FDA", "@entity-id": "7524"}], "#text": "In April 2012,\n\t\t\t the "}, "enum": {"#tail": "\n        ", "#text": "(18)"}, "@id": "HB142E969E9204A3695D98E3832537E80", "#text": "\n        "}, {"#tail": "\n      ", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "In January 2013,\n\t\t\t Consumer Reports published test results on pork products bought in grocery\n\t\t\t stores nationwide showing disturbingly high levels of Salmonella and Yersinia\n\t\t\t enterocolitica bacteria that were resistant to the antibiotics used to treat\n\t\t\t food borne illnesses. A 2003 Consumer Report study showed similar results in\n\t\t\t poultry products."}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@display-inline": "yes-display-inline", "#text": "\n          ", "@id": "H3F28C0EDD9E24F51B61485F85DDA4E17", "@commented": "no"}, {"@indent": "up1", "#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2019s\n\t\t\t National Antimicrobial Resistance Monitoring System routinely finds that retail\n\t\t\t meat products are contaminated with bacteria (including the foodborne pathogens\n\t\t\t Campylobacter and Salmonella) that are resistant to antibiotics important in\n\t\t\t human medicine. The 2011 National Antimicrobial Resistance Monitoring System\n\t\t\t report found that the percentage of meat containing antibiotic resistant\n\t\t\t bacteria increases each year and that many of these bacteria exhibit multiple\n\t\t\t antibiotic resistance.", "@entity-type": "federal-body", "#text": "Food and Drug Administration", "@entity-id": "7524"}, "#text": "The "}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "#text": "\n          ", "@id": "H7EFBB75AB32C4034AFF439A1FC9042C2"}], "enum": {"#tail": "\n        ", "#text": "(19)"}, "@id": "H53E1AE89D88E4848B043B4D8D6E3736D", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Antibiotic\n\t\t\t resistance, resulting in a reduced number of effective antibiotics, may\n\t\t\t significantly impair the ability of the United States to respond to terrorist\n\t\t\t attacks involving bacterial infections or a large influx of hospitalized\n\t\t\t patients."}, "enum": {"#tail": "\n        ", "#text": "(20)"}, "@id": "HE65A279F891F4FBFACE173C7B94BB9BF", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Many scientific\n\t\t\t studies confirm that the nontherapeutic use of antibiotics in agricultural\n\t\t\t animals contribute to the development of antibiotic-resistant bacterial\n\t\t\t infections in people."}, "enum": {"#tail": "\n        ", "#text": "(21)"}, "@id": "HCB28D12EDC144A00980849F46D8453F6", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Epidemiological\n\t\t\t research has shown that resistant Salmonella and Campylobacter infections are\n\t\t\t associated with increased numbers of ill patients and bloodstream infections,\n\t\t\t and increased death."}, "enum": {"#tail": "\n        ", "#text": "(22)"}, "@id": "H5DC8017AE1404E0CB633EE82493DF4CB", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "The American\n\t\t\t Medical Association, the American Public Health Association, the National\n\t\t\t Association of County and City Health Officials, and the National Sustainable\n\t\t\t Agriculture Coalition are among the over 400 organizations representing health,\n\t\t\t consumer, agricultural, environmental, humane, and other interests that have\n\t\t\t supported enactment of legislation to phase out nontherapeutic use in farm\n\t\t\t animals of medically important antimicrobials."}, "enum": {"#tail": "\n        ", "#text": "(23)"}, "@id": "H4DAE6857B0924281BC39DF279062AD5D", "#text": "\n        "}], "#text": "\n      ", "@id": "H0D39B9940E9540168E421C3AF6E43360"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t", "#text": "The purpose of this Act is to preserve the\n\t\t\t effectiveness of medically important antimicrobials used in the treatment of\n\t\t\t human and animal diseases.", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Purpose"}, "#text": "\n      ", "@id": "H79549DAE2C4E4302BFDFD268E2F21071"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "Proof of safety\n\t\t\t of medically important antimicrobials"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 512(d)(1) of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:1"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 360b(d)(1)", "@value": "usc/21/360b/d/1"}, "@parsable-cite": "usc/21/360b", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Applications\n\t\t\t pending or submitted after enactment"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "in the first\n\t\t\t sentence\u2014"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "HDCAAE38161384355A993DE33D7F5109E", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (H)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:1/sp:H"}, "#text": "in ", "quote": {"#tail": " at the end;", "#text": "or"}}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H25F1E62275C84A8E8A7B23232457EC06", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by inserting ", "@entity-type": "act", "#text": "subparagraph\n\t\t\t (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:1/sp:I"}, "#text": "in ", "quote": {"#tail": " at the end; and", "#text": "or"}}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H4E7384A50574489D9A04E3B89A55DB6D", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the following:", "@entity-type": "act", "#text": "subparagraph (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:1/sp:I"}, "#text": "by inserting after\n\t\t\t "}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": ";\n\t\t\t\tand"}, "#tail": "\n\t\t\t\t\t", "subparagraph": {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "), the applicant\n\t\t\t\thas failed to demonstrate that there is a reasonable certainty of no harm to\n\t\t\t\thuman health due to the development of antimicrobial resistance that is\n\t\t\t\tattributable, in whole or in part, to the nontherapeutic use (as defined in\n\t\t\t\t", "@entity-type": "act", "#text": "subsection (q)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q", "@proposed": "true"}, {"#tail": ") of the medically important antimicrobial or\n\t\t\t\tdrug;", "@entity-type": "act", "#text": "subsection (q)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q", "@proposed": "true"}], "#text": "with respect to a\n\t\t\t\tmedically important antimicrobial (as defined in "}, "enum": {"#tail": "\n                ", "#text": "(J)"}, "@id": "HD2DA9C9482C0498387E774830E8E4A2B", "#text": "\n                "}, "#text": "\n\t\t\t\t\t\t\t", "@id": "H7DBB8DA351664928927920ACCE183690"}, "#text": "\n            ", "@id": "H5B3E05DD3BD9474AB1255052B999C902"}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "quote": [{"#tail": " and inserting ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "(A) through (I)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:1/sp:A..I"}, "#text": "\n              "}, {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "act", "#text": "(A)\n\t\t\t through (J)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:d/p:1/sp:A..J", "@proposed": "true"}, "#text": "\n              "}], "#text": "in the second\n\t\t\t sentence, by striking "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H2369384792E64BF2AAE755401B1E6336", "#text": "\n          "}], "#text": "\n        ", "@id": "HF2A8078D34EF41DBB09055B5D9519C6F"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the\n\t\t\t following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 512 of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 360b", "@value": "usc/21/360b"}, "@parsable-cite": "usc/21/360b", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Phased\n\t\t\t elimination of nontherapeutic use in animals of medically important\n\t\t\t antimicrobials"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(q)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Phased\n\t\t\t\telimination of nontherapeutic use in animals of medically important\n\t\t\t\tantimicrobials"}, "paragraph": [{"#tail": "\n            ", "@id": "H194FDEE1648841B4A4E6CFEFE77CE31D", "enum": {"#tail": "\n              ", "#text": "(1)"}, "header": {"#tail": "\n              ", "#text": "Applicability"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "This\n\t\t\t\tparagraph applies to the nontherapeutic use in a food-producing animal of a\n\t\t\t\tdrug\u2014"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "that is a\n\t\t\t\tmedically important antimicrobial; or"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HB7AB4C61985C4CE696ED2541EB89CBD3", "#text": "\n                "}, {"#tail": "\n            ", "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "subsection (b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": ",\n\t\t\t\tor ", "@entity-type": "act", "#text": "(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:i"}, {"#tail": "; or", "@entity-type": "act", "#text": "(j) of section 505", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}], "#text": "for which there is in\n\t\t\t\teffect an approval of an application or an exemption under "}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@display-inline": "yes-display-inline", "#text": "\n                  ", "@id": "H5721EBEA666C4931835D5334FFED9191", "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "that is otherwise marketed for\n\t\t\t\thuman use."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "#text": "\n                  ", "@id": "H8434ED9E83804792869AB964D339AE7B"}], "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H41862A6C7D9C4710BB38B03ED3BD856F", "#text": "\n                "}]}, {"#tail": "\n            ", "@id": "H7957C19A34A94E9B9D0E22CCCC6A69A4", "enum": {"#tail": "\n              ", "#text": "(2)"}, "header": {"#tail": "\n              ", "#text": "Withdrawal"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall withdraw the approval of a nontherapeutic use in food-producing\n\t\t\t\tanimals of a drug described in ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, {"#tail": " on the date that is 2 years after\n\t\t\t\tthe date of enactment of this subsection unless\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q/p:1", "@proposed": "true"}], "#text": "The\n\t\t\t\t"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " makes a final written determination that the holder of the approved\n\t\t\t\tapplication has demonstrated that there is a reasonable certainty of no harm to\n\t\t\t\thuman health due to the development of antimicrobial resistance that is\n\t\t\t\tattributable in whole or in part to the nontherapeutic use of the drug;\n\t\t\t\tor", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, "#text": "before the date\n\t\t\t\tthat is 2 years after the date of the enactment of this subsection, the\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H99AA7430D712415F9B4C63181BE1F8DF", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q/p:2/sp:A", "@proposed": "true"}, {"#tail": " makes a final written\n\t\t\t\tdetermination under this subsection, with respect to a risk analysis of the\n\t\t\t\tdrug conducted by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, {"#tail": " and other relevant information, that there is a\n\t\t\t\treasonable certainty of no harm to human health due to the development of\n\t\t\t\tantimicrobial resistance that is attributable in whole or in part to the\n\t\t\t\tnontherapeutic use of the drug.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}], "#text": "before the date\n\t\t\t\tspecified in "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H1E6BAEC3B39941C7945D3EA228FE4015", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", if the ", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q/p:5", "@proposed": "true"}, {"#tail": " grants an exemption under\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, {"#tail": " for a drug that is a medically important antimicrobial, the\n\t\t\t\t", "@entity-type": "act", "#text": "section 505(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:i"}, {"#tail": " shall rescind each approval of a nontherapeutic use in a\n\t\t\t\tfood-producing animal of the medically important antimicrobial, as of the date\n\t\t\t\tthat is 2 years after the date on which the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, {"#tail": " grants the\n\t\t\t\texemption.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}], "#text": "Except\n\t\t\t\tas provided in "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "header": {"#tail": "\n              ", "#text": "Exemptions"}, "#text": "\n              ", "@id": "HA9C1575E3794454FBCC4D4377D53C85F"}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", if an application for a drug that is a medically\n\t\t\t\timportant antimicrobial is submitted to the ", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q/p:5", "@proposed": "true"}, {"#tail": " under ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, {"#tail": ", the\n\t\t\t\t", "@entity-type": "act", "#text": "section 505(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": " shall rescind each approval of a nontherapeutic use in a\n\t\t\t\tfood-producing animal of the medically important antimicrobial, as of the date\n\t\t\t\tthat is 2 years after the date on which the application is submitted to the\n\t\t\t\t", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, {"#tail": ".", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}], "#text": "Except\n\t\t\t\tas provided in "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "header": {"#tail": "\n              ", "#text": "Approvals"}, "#text": "\n              ", "@id": "HB9EAE4BA53154A53A54AE3C0F557944F"}, {"#tail": "\n            ", "@id": "HE2C2F483273F4242B84001BC950E9E2B", "enum": {"#tail": "\n              ", "#text": "(5)"}, "header": {"#tail": "\n              ", "#text": "Exceptions"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "Paragraph\n\t\t\t\t(3)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q/p:3", "@proposed": "true"}, {"#tail": ", as the case may be, shall not apply if\u2014", "@entity-type": "act", "#text": "(4)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q/p:4", "@proposed": "true"}], "#text": "\n                "}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " makes a\n\t\t\t\tfinal written determination that the holder of the application for the approved\n\t\t\t\tnontherapeutic use has demonstrated that there is a reasonable certainty of no\n\t\t\t\tharm to human health due to the development of antimicrobial resistance that is\n\t\t\t\tattributable in whole or in part to the nontherapeutic use in the\n\t\t\t\tfood-producing animal of the medically important antimicrobial; or", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, "#text": "before the date on\n\t\t\t\twhich approval would be rescinded under that paragraph, the "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "HB768282DA46C4ECA8A2BB99765A5968A", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q/p:5/sp:A", "@proposed": "true"}, {"#tail": " makes a final written\n\t\t\t\tdetermination, with respect to a risk analysis of the medically important\n\t\t\t\tantimicrobial conducted by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}, {"#tail": " and any other relevant information,\n\t\t\t\tthat there is a reasonable certainty of no harm to human health due to the\n\t\t\t\tdevelopment of antimicrobial resistance that is attributable in whole or in\n\t\t\t\tpart to the nontherapeutic use of the medically important antimicrobial.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "1200"}], "#text": "before the date\n\t\t\t\tspecified in "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HAEB376E190F74B078D9BECDA88D69C94", "#text": "\n                "}]}, {"#tail": "\n          ", "@id": "H8345B1B0B472438394492D269DAF97E5", "enum": {"#tail": "\n              ", "#text": "(6)"}, "header": {"#tail": "\n              ", "#text": "Definition"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis subsection:"}, "#text": "\n              ", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means a drug that\u2014", "#text": "medically important antimicrobial"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is\n\t\t\t\tintended for use in food-producing animals; and"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H82E049A3B32644AFB987CFC6A9311956", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "is composed\n\t\t\t\twholly or partly of\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "any kind of\n\t\t\t\tpenicillin, tetracycline, macrolide, lincosamide, streptogramin,\n\t\t\t\taminoglycoside, sulfonamide, or cephalosporin; or"}, "enum": {"#tail": "\n                    ", "#text": "(I)"}, "@id": "HED66A36DA17544AFBC37FA805AB89E52", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "quote": [{"#tail": ",\n\t\t\t\t", "#text": "highly important"}, {"#tail": ", or ", "#text": "critically important"}, {"#tail": " by the ", "#text": "important"}, {"#tail": " (or a\n\t\t\t\tsuccessor publication).", "#text": "Critically Important Antimicrobials for Human Medicine"}], "#text": "a drug from an\n\t\t\t\tantimicrobial class that is listed as ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " in the latest edition of its publication entitled\n\t\t\t\t", "@entity-type": "federal-body", "#text": "World\n\t\t\t\tHealth Organization", "@entity-id": "19UH"}}, "enum": {"#tail": "\n                    ", "#text": "(II)"}, "@id": "H4E0B81DCAAFB4A6089EF43F3E85077F0", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H8444E9CF213D4DEF9337399D17108667"}], "#text": "\n                ", "@id": "HCA28B5A9E2324B55B3EF10A07D6ECD4C"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": ", with respect to a medically important\n\t\t\t\tantimicrobial, means the use of antimicrobials for the specific purpose of\n\t\t\t\ttreating an animal with a documented disease or infection. Such term does not\n\t\t\t\tinclude the continued use of such an antimicrobial in the animal after the\n\t\t\t\tdisease or infection is resolved.", "#text": "therapeutic use"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "HBA377744093B48AF989800C197C005BC", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": "\u2014", "#text": "nontherapeutic use"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "clause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "means administration of antibiotics to an\n\t\t\t\tanimal through feed and water (or, in poultry hatcheries, through any means)\n\t\t\t\tfor purposes (such as growth promotion, feed efficiency, weight gain, or\n\t\t\t\tdisease prevention) other than therapeutic use or nonroutine disease control;\n\t\t\t\tand", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                  ", "#text": "(i)"}, "@id": "H4589D9B88AD54725932EB11C1A0ACAE7", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "includes any\n\t\t\t\trepeated or regular pattern of use of medically important antimicrobials for\n\t\t\t\tpurposes other than therapeutic use or nonroutine disease control."}, "enum": {"#tail": "\n                  ", "#text": "(ii)"}, "@id": "H0CE62A7E08494AB995E4B32AACA158D3", "#text": "\n                  "}], "#text": "\n                ", "@id": "H0904003026DA40A0B125D0979E9E6676"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " does not include normal or standard\n\t\t\t\tpractice and conditions on the premises that facilitate the transmission of\n\t\t\t\tdisease.", "#text": "noncustomary situation"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "@id": "HF054247501E64F379185EE38DD85A3A4", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means the use of antibiotics on an animal that is not sick but\n\t\t\t\twhere it can be shown that a particular disease or infection is present, or is\n\t\t\t\tlikely to occur because of a specific, noncustomary situation, on the premises\n\t\t\t\tat the barn, house, pen, or other level at which the animal is\n\t\t\t\tkept.", "#text": "nonroutine disease\n\t\t\t\tcontrol"}, "#text": "The term ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(E)"}, "@id": "HEF50AD028E6543FE89CF04D8B166AEF8", "#text": "\n                "}]}], "#text": "\n            ", "@id": "HC2CF2463631B4195AFCCF82ECB3F0A2F"}, "#text": "\n\t\t\t\t\t", "@id": "H0032508606FA496AB9891225265DDC2C"}, "#text": "\n        ", "@id": "H0AD6E75193CE4D049107DBB187E8BCB9"}], "#text": "\n      ", "@id": "H8622D991CFD84C93AFFB17E342DE050A"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "5."}, "header": {"#tail": "\n\t\t\t", "#text": "Limitations on\n\t\t\t use of medically important antimicrobials for nonroutine disease\n\t\t\t control"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at\n\t\t\t the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 301 of the\n\t\t\t Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:301"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 331", "@value": "usc/21/331"}, "@parsable-cite": "usc/21/331", "#text": "\n              ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Prohibited\n\t\t\t acts"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t512A", "@value": "Federal Food, Drug, and Cosmetic Act/s:512A"}, "#text": "The administration of a medically important\n\t\t\t\tantimicrobial to a food-producing animal for nonroutine disease control in\n\t\t\t\tviolation of the requirements of ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(ccc)"}, "@id": "HF777B5A6D1004E0C9E317ECCEE925C4F", "#text": "\n            "}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "HB07E4CF6A6EE4883AD361B456B5D9658"}, "#text": "\n        ", "@id": "HBC5006A58C6B422D923C12CB0FB12108"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is amended by inserting after ", "@entity-type": "act", "#text": "Chapter V of the Federal Food, Drug, and\n\t\t\t Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/ch:V"}, "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " the following:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "section 512 of such Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:512"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C.\n\t\t\t 360b", "@value": "usc/21/360b"}], "@entity-type": "law-citation", "#text": "\n            "}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Requirements"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "section": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "512A."}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Limitations on\n\t\t\t\tuse of medically important antimicrobials for nonroutine disease\n\t\t\t\tcontrol"}, "subsection": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "It shall be unlawful to administer\n\t\t\t\t(including by means of animal feed) a medically important antimicrobial to a\n\t\t\t\tfood-producing animal for nonroutine disease control unless\u2014", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(a)"}, "header": {"#tail": "\n              ", "#text": "Prohibition"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "there is a\n\t\t\t\tsignificant risk that a disease or infection present on the premises will be\n\t\t\t\ttransmitted to the food-producing animal;"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "H4A34BDAA099641D3B5741EC990388579", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ";", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512A/ss:a/p:1", "@proposed": "true"}, "#text": "the administration of the medically\n\t\t\t\timportant antimicrobial to the food-producing animal is necessary to prevent or\n\t\t\t\treduce the risk of transmission of the disease or infection described in\n\t\t\t\t", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "H9DD705F3DC1B4A58A5020437BA9A582C", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " to the animal; and", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512A/ss:a/p:1", "@proposed": "true"}, "#text": "the medically important antimicrobial is\n\t\t\t\tadministered to the food-producing animal for nonroutine disease control for\n\t\t\t\tthe shortest duration possible to prevent or reduce the risk of transmission of\n\t\t\t\tthe disease or infection described in ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(3)"}, "@id": "H43B3108EBD9C43E7957B220E767827C3", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the medically\n\t\t\t\timportant antimicrobial is administered\u2014"}, "enum": {"#tail": "\n                ", "#text": "(4)"}, "#text": "\n                ", "@id": "HBEA645DB04974221B2CF8FE5C1A5C65A", "subparagraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "at a scale no\n\t\t\t\tgreater than the barn, house, or pen level; and"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "@id": "HB88BAF6EF199413EA89AEB1878CA2532", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512A/ss:a/p:1", "@proposed": "true"}, "#text": "to the fewest\n\t\t\t\tanimals possible to prevent or reduce the risk of transmission of the disease\n\t\t\t\tor infection described in "}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "H142B958480624D6984D3153B221F830B", "#text": "\n                  "}]}], "#text": "\n              ", "@id": "H44583495FFD54A439826FE8C71291E6D"}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthis section:"}, "enum": {"#tail": "\n              ", "#text": "(b)"}, "header": {"#tail": "\n              ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": " means a food-producing animal intended for\n\t\t\t\tsale in interstate commerce.", "#text": "food-producing animal"}, "#text": "The term\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(1)"}, "@id": "H5A5AFAFC6DC64E69B6F311BAE89B9C48", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section\n\t\t\t\t512(q)", "@value": "Federal Food, Drug, and Cosmetic Act/s:512/ss:q", "@proposed": "true"}, "term": [{"#tail": " and ", "#text": "medically important antimicrobial"}, {"#tail": " have the meanings given to such terms in ", "#text": "nonroutine disease\n\t\t\t\tcontrol"}], "#text": "The terms\n\t\t\t\t"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "@id": "HE933310405704112AE590E64592ABEDA", "#text": "\n                "}], "#text": "\n              ", "@id": "HA8E5416CC0604458B5E70D9F2DAF017D"}], "#text": "\n            ", "@id": "H28ADC5A48B4448B2B73ABA9A40475630"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "HF9D11212C4BC46D39514BAB341F190E5"}, "#text": "\n        ", "@id": "HF4C330E44CC64C569BF765BA6829E1C4"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "The\n\t\t\t amendments made by this section apply beginning on the date that is 6 months\n\t\t\t after the date of the enactment of this Act."}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Applicability"}, "#text": "\n        ", "@id": "H781A848210974637852B381EC049906C"}], "#text": "\n      ", "@id": "HBBDA23D72DDF48BEBE30D2B5A26B6F17"}], "#text": "\n\t\t", "@id": "HBD4A645823F04386A0B52903F778D522"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-03-14"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 1150 IH: Preservation of Antibiotics for Medical Treatment Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}